Results 261 to 270 of about 163,907 (339)
Immune-modulating therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF) in refractory rhino-orbital-cerebral mucormycosis - a case report. [PDF]
Thayanantham P +5 more
europepmc +1 more source
New therapeutic strategy for recalcitrant eyelid and orbital diseases
Shu‐Lang Liao
openalex +1 more source
This study identifies POLD4 as a potential prostate cancer radiosensitization target through transcriptome sequencing. By encapsulating POLD4‐targeted CRISPR/Cas9 plasmids and USPIONs in cationic liposomes, an MRI‐monitored gene‐editing platform is established.
Xuhui Fan +10 more
wiley +1 more source
Interleukin-27 is a multitarget regulator of fibroblast remodeling in thyroid-associated ophthalmopathy. [PDF]
Zhang P +5 more
europepmc +1 more source
PtRhIr/Ru SAN@M nanozymes cross the blood–brain barrier and selectively accumulate in hemorrhagic brain regions. By mimicking multiple enzyme activities, they attenuate oxidative stress, modulate microglial polarization toward an anti‐inflammatory phenotype, inhibit ferroptosis, and promote neuronal repair.
Jiebo Li +17 more
wiley +1 more source
A Case of Recurrent Painful Ophthalmoplegia Following COVID-19: Evolution From Optic Neuritis to Tolosa-Hunt Syndrome. [PDF]
Poudel S +5 more
europepmc +1 more source
Skeletal Analysis of Three Bluff Shelter Burials [PDF]
Hickman, H. Eugene, Jr.
core +2 more sources
This study uncovered a dual‐track mechanism by which ADAMTS9‐AS2 overcame chemoresistance in CRPC: suppressing cancer stemness through the FOXF2/TGF‐β2 pathway, and triggering ferroptosis via competitive SLC7A11 sequestration. Polymeric materials co‐targeting these vulnerabilities further boost docetaxel sensitivity, highlighting a compelling strategy ...
Ji Liu +12 more
wiley +1 more source

